ADDITION OF LENALIDOMIDE TO R-CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG-ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R-CHOP-Reference-Cited by-同舟云学术

ADDITION OF LENALIDOMIDE TO R-CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG-ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R-CHOP

Published:2019-06 Issue: Volume:37 Page:37-38
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Nowakowski G.S.¹,Hong F.²,Scott D.W.³,Macon R.⁴,King R.L.⁴,Habermann T.M.¹,Wagner-Johnston N.⁵,Casulo C.⁶,Wade J.L.⁷,Nagargoje G.G.⁸,Reynolds C.M.⁹,Cohen J.B.¹⁰,Khan N.¹¹,Amengual J.¹²,Richards K.L.¹³,Little R.F.¹⁴,Leonard J.P.¹³,Friedberg J.W.⁶,Kostakoglu L.¹⁵,Kahl B.S.³,Witzig T.E.¹

Affiliation:

1. Division of Hematology; Mayo Clinic; Rochester MN USA

2. Department of Biostatistics; Dana Farber Cancer Institute; Boston MA USA

3. British Columbia Cancer Center for Lymphoid Cancer; Vancouver Canada

4. Division of Hematopathology; Mayo Clinic Rochester MN; USA

5. Johns Hopkins University; Baltimore Maryland USA

6. University of Rochester; NY USA

7. Heartland NORP; Decatur IL USA

8. Marcy Hospital; Coon Rapids MN USA

9. Saint Joseph Mercy Hospital; Ann Arbor MI USA

10. Emory University-Winship Cancer Institute; Atlanta GA USA

11. Fox Case Cancer Center; Philadelphia PA USA